Mari Giancarlo, Hanif Farhan
Wayne State University, Detroit, MI 48201, USA.
Clin Obstet Gynecol. 2007 Jun;50(2):497-509. doi: 10.1097/GRF.0b013e31804c96a9.
Intrauterine growth restriction secondary to placental insufficiency is a major cause of perinatal morbidity and mortality in the United States. Once intrauterine growth restriction is identified, obstetrical management is focused on assuring safety while the fetus continues to mature within a potentially hostile intrauterine environment. In the United States, the approach to management and delivery of the premature growth-restricted fetus is often based on serial biophysical profile evaluations, whereas in Europe it is usually based on the results of cardiotocography. However, there is no single test that seems superior to the other available tests for timing the delivery of the growth-restricted fetus. Therefore, the decision to deliver a fetus, especially at <32 weeks, remains mostly on the basis of empirical management.
在美国，胎盘功能不全继发的宫内生长受限是围产期发病和死亡的主要原因。一旦确诊宫内生长受限，产科管理的重点是在胎儿继续在潜在不利的宫内环境中成熟的同时确保安全。在美国，对于早产且生长受限胎儿的管理和分娩方法通常基于连续的生物物理评分评估，而在欧洲则通常基于胎心监护的结果。然而，对于确定生长受限胎儿的分娩时机，没有一种检查似乎优于其他现有检查。因此，尤其是在孕32周前分娩胎儿的决定大多基于经验性管理。
